Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Respiratory diseases stories

Nov 13, 2026

Windward Bio prices $175M IPO to advance China-licensed lung drugs

Swiss immune drug developer Windward Bio raised $175 million in its IPO, the biotech sector's 30th listing of the year, to advance lung disease drugs licensed from China.

Nov 13, 2026·2 sources
00
Oct 30, 2026

FDA approves Inovio's Voceryq for recurrent respiratory papillomatosis

The U.S. Food and Drug Administration has approved Inovio Pharmaceuticals' treatment Voceryq for recurrent respiratory papillomatosis, a rare throat disease. The approval sent Inovio's shares surging.

Oct 30, 2026·4 sources
00
Oct 29, 2026

ECDC report finds universal RSV immunization could significantly reduce infant hospitalizations in Europe

A new report from the European Centre for Disease Prevention and Control indicates that universal immunization of newborns against respiratory syncytial virus could significantly reduce infant hospitalizations across the EU. The findings come as the RSV season approaches, with evidence showing national programs using nirsevimab or maternal vaccination are associated with large reductions in infant hospitalizations.

Oct 29, 2026·2 sources
00
Oct 8, 2026

Endeavor BioMedicines' taladegib meets primary endpoint in phase 2b trial for idiopathic pulmonary fibrosis

Endeavor BioMedicines announced that its WHISTLE-PF phase 2b trial of taladegib met its primary endpoint, demonstrating statistically significant improvement in lung function (ppFVC) compared to placebo in patients with IPF. The company claims the drug has potential to reverse disease course, unlike current therapies that only slow progression.

Oct 8, 2026·2 sources
00
Oct 2, 2026

TTHealthWatch podcast covers new treatment target for asthma and COPD

The weekly podcast from Texas Tech University features discussion of a new therapeutic target for asthma and chronic obstructive pulmonary disease, along with other top medical stories. The podcast is co-hosted by Elizabeth Tracey of Johns Hopkins Medicine and Dr. Rick Lange of Texas Tech Health El Paso.

Oct 2, 2026·3 sources
00
Sep 8, 2026

AstraZeneca's experimental COPD drug significantly reduces flare-ups in late-stage trials

AstraZeneca's experimental drug for chronic obstructive pulmonary disease significantly reduced dangerous flare-ups across a wide range of patients in two late-stage trials, positioning it as a potential blockbuster treatment for the deadly lung condition.

Sep 8, 2026·3 sources
00

AstraZeneca's experimental COPD drug shows strong results in late-stage trials

AstraZeneca released full results from two successful late-stage trials showing its experimental drug significantly reduced dangerous flare-ups in chronic obstructive pulmonary disease patients across a broad patient population, boosting the treatment's blockbuster potential.

Sep 8, 2026·8 sources
00
Jul 9, 2026

Moderna Wins EU Contract for RSV Vaccine Supply

Moderna has secured a contract with the European Union to supply its respiratory syncytial virus (RSV) vaccine, expanding the company's vaccine portfolio beyond COVID-19.

Jul 9, 2026·1 source
00

Top claims

  • ▪Sanofi purchased $50 million of shares and pre-funded warrants in a private stock placement concurrent with Windward Bio's initial public offering
  • ▪Windward Bio begins trading on November 13, 2026 under the ticker symbol WWB
  • ▪Biopharmaceutical initial public offerings have raised over $8 billion in 2026, marking the sector's busiest IPO year since 2021

Subtopics

Biotechnology3Drug Policy, Pricing & Approval3Pharmaceutical Industry3Asthma2Clinical trials2COPD2Drug Approval and Clinical Trials2Infectious Disease and Outbreaks2Pharma2Rare diseases2Vaccines and Immunization Policy2Accelerated approval pathways1Biotech innovation1Child health1Drug development1Epidemiology1FDA drug approval1Immunotherapy1Medical research1Public health1Public healthcare1Vaccination programs1Vaccine access and delivery1Vaccine development1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories